Calithera Biosciences, Inc. 4 SEC Filings

Filed On	Filing
26 May 2023	Form 4: Takeda Pharmaceutical Co Ltd, Former 10% Owner and 1 other Disposed of 1,000,000 Series A Convertible Preferred Stock (Other Transaction)
31 Jan 2023	Form 4: Pakianathan Deepika, Director Sold 121,333 shares ($46.8K)
25 Jan 2023	Form 4: Sjogren Eric, SR. VP, DRUG DISCOVERY Gave up 279 shares to cover exercise price or tax ($124)
25 Jan 2023	Form 4: Kuriakose Emil, CHIEF MEDICAL OFFICER Gave up 79 shares to cover exercise price or tax ($35.2)
25 Jan 2023	Form 4: Molineaux Susan, Director Gave up 526 shares to cover exercise price or tax ($235)
25 Jan 2023	Form 4: Wong Stephanie, See Remarks Gave up 317 shares to cover exercise price or tax ($141)
25 Jan 2023	Form 4: Molineaux Christopher, SR. VP, DEVELOPMENT Gave up 217 shares to cover exercise price or tax ($96.8)
06 Jul 2022	Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other Disposed of 1,000,000 Series A Convertible Preferred Stock (Other Transaction) · Acquired 1,000,000 Series A Convertible Preferred Stock (Other Transaction)
03 Jun 2022	Form 4: Jones Suzy, Director Granted 20,000 Stock Option (Right to Buy)
03 Jun 2022	Form 4: Pakianathan Deepika, Director Granted 20,000 Stock Option (Right to Buy)
03 Jun 2022	Form 4: Agarwal Sunil, Director Granted 20,000 Stock Option (Right to Buy)
03 Jun 2022	Form 4: Garland J. Scott, Director Granted 20,000 Stock Option (Right to Buy)
03 Jun 2022	Form 4: Wise Blake, Director Granted 20,000 Stock Option (Right to Buy)
03 Jun 2022	Form 4: Orford Keith, Director Granted 20,000 Employee Stock Option (Right to Buy)
03 Jun 2022	Form 4: Wolff Henry Ward, Director Granted 20,000 Stock Option (Right to Buy)
27 Jan 2022	Form 4: Molineaux Susan, Director Granted 597,475 Employee Stock Option (Right to Buy)
27 Jan 2022	Form 4: Wong Stephanie, See Remarks Granted 215,000 Employee Stock Option (Right to Buy)
27 Jan 2022	Form 4: Ray Sumita, See Remarks Granted 165,000 Employee Stock Option (Right to Buy)
27 Jan 2022	Form 4: Sjogren Eric, SR. VP, DRUG DISCOVERY Granted 165,000 Employee Stock Option (Right to Buy)
27 Jan 2022	Form 4: Parlati Francesco, SR. VP, RESEARCH Granted 165,000 Employee Stock Option (Right to Buy)

Comments